Unknown

Dataset Information

0

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.


ABSTRACT: The insulin-like growth factor (IGF) pathway has been implicated in prostate development and carcinogenesis. We conducted a comprehensive analysis, utilizing a resequencing and tagging single-nucleotide polymorphism (SNP) approach, between common genetic variation in the IGF1, IGF binding protein (BP) 1, and IGFBP3 genes with IGF-I and IGFBP-3 blood levels, and prostate cancer (PCa) risk, among Caucasians in the NCI Breast and Prostate Cancer Cohort Consortium. We genotyped 14 IGF1 SNPs and 16 IGFBP1/IGFBP3 SNPs to capture common [minor allele frequency (MAF) >or= 5%] variation among Caucasians. For each SNP, we assessed the geometric mean difference in IGF blood levels (N = 5684) across genotypes and the association with PCa risk (6012 PCa cases/6641 controls). We present two-sided statistical tests and correct for multiple comparisons. A non-synonymous IGFBP3 SNP in exon 1, rs2854746 (Gly32Ala), was associated with IGFBP-3 blood levels (P(adj) = 8.8 x 10(-43)) after adjusting for the previously established IGFBP3 promoter polymorphism A-202C (rs2854744); IGFBP-3 blood levels were 6.3% higher for each minor allele. For IGF1 SNP rs4764695, the risk estimates among heterozygotes was 1.01 (99% CI: 0.90-1.14) and 1.20 (99% CI: 1.06-1.37) for variant homozygotes with overall PCa risk. The corrected allelic P-value was 8.7 x 10(-3). IGF-I levels were significantly associated with PCa risk (P(trend) = 0.02) with a 21% increase of PCa risk when compared with the highest quartile to the lowest quartile. We have identified SNPs significantly associated with IGFBP-3 blood levels, but none of these alter PCa risk; however, a novel IGF1 SNP, not associated with IGF-I blood levels, shows preliminary evidence for association with PCa risk among Caucasians.

SUBMITTER: Schumacher FR 

PROVIDER: S-EPMC2901143 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

Schumacher Fredrick R FR   Cheng Iona I   Freedman Matthew L ML   Mucci Lorelei L   Allen Naomi E NE   Pollak Michael N MN   Hayes Richard B RB   Stram Daniel O DO   Canzian Federico F   Henderson Brian E BE   Hunter David J DJ   Virtamo Jarmo J   Manjer Jonas J   Gaziano J Michael JM   Kolonel Laurence N LN   Tjønneland Anne A   Albanes Demetrius D   Calle Eugenia E EE   Giovannucci Edward E   Crawford E David ED   Haiman Christopher A CA   Kraft Peter P   Willett Walter C WC   Thun Michael J MJ   Le Marchand Loïc L   Kaaks Rudolf R   Feigelson Heather Spencer HS   Bueno-de-Mesquita H Bas HB   Palli Domenico D   Riboli Elio E   Lund Eiliv E   Amiano Pilar P   Andriole Gerald G   Dunning Alison M AM   Trichopoulos Dimitrios D   Stampfer Meir J MJ   Key Timothy J TJ   Ma Jing J  

Human molecular genetics 20100519 15


The insulin-like growth factor (IGF) pathway has been implicated in prostate development and carcinogenesis. We conducted a comprehensive analysis, utilizing a resequencing and tagging single-nucleotide polymorphism (SNP) approach, between common genetic variation in the IGF1, IGF binding protein (BP) 1, and IGFBP3 genes with IGF-I and IGFBP-3 blood levels, and prostate cancer (PCa) risk, among Caucasians in the NCI Breast and Prostate Cancer Cohort Consortium. We genotyped 14 IGF1 SNPs and 16 I  ...[more]

Similar Datasets

| S-EPMC2792318 | biostudies-literature
| S-EPMC2925500 | biostudies-literature
| S-EPMC4360136 | biostudies-literature
| S-EPMC3075867 | biostudies-literature
| S-EPMC3238452 | biostudies-literature